Physician profile
Mohammad Majd
NPI 1659362994
$504,048.95
in general payments reported to CMS, 2019-2025
29 companies · $105K in 2025
The $105K reported for 2025 was more than what 92% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $52K · 2021: $73K · 2022: $90K · 2023: $79K · 2024: $88K · 2025: $105K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $271K · Travel and Lodging: $1,796 · Food and Beverage: $60.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $270,525.00 |
| Travel and Lodging | $1,795.50 |
| Food and Beverage | $60.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spineart Sa | $474,027.00 | 2019-2025 | Scarlet Al-T - Secured Lumbar Anterior Cage |
| Spineart USA INC | $11,522.78 | 2019-2023 | Cure Acp |
| Surgalign Spine Technologies, INC. | $8,445.72 | 2019-2021 | |
| The Institute of Musculoskeletal Science and Education | $2,955.30 | 2019-2020 | |
| Camber Spine Technologies LLC | $2,827.94 | 2020-2021 | |
| Life Spine, INC. | $802.11 | 2019-2020 | |
| Medtronic USA, INC. | $787.95 | 2019-2020 | |
| Alphatec Spine, INC | $580.16 | 2019 | |
| Amgen INC. | $468.28 | 2019-2021 | |
| Providence Medical Technology, INC. | $467.71 | 2019-2021 | |
| 7d Surgical INC. | $222.80 | 2020 | |
| Boston Scientific Corporation | $140.85 | 2021 | |
| Nexxt Spine LLC | $124.03 | 2022 | |
| 4web, INC. | $102.86 | 2019 | |
| Medtronic, INC. | $91.07 | 2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alevio, LLC | $82.14 | 2019 | |
| Depuy Synthes Sales INC. | $72.01 | 2019-2020 | |
| Centinel Spine, LLC | $70.32 | 2019 | |
| Baxter Healthcare | $61.41 | 2021 | |
| Zimmer Biomet Holdings, INC. | $46.64 | 2019-2020 | |
| Nuvasive, INC. | $37.76 | 2020 | |
| Abbott Laboratories | $23.46 | 2021 | |
| Nanovis LLC | $22.66 | 2019-2020 | |
| Ethicon US, LLC | $16.04 | 2019 | |
| Medacta USA, INC. | $14.36 | 2019 | |
| Pfizer INC. | $12.96 | 2019 | |
| Horizon Therapeutics Plc | $11.33 | 2019 | |
| Zyla Life Sciences, INC. | $11.30 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$315.15 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Majd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.